Pharmacogenetic tools for antidepressant prescribing have limited evidence base.
- Published in:
- Brown University Psychopharmacology Update, 2018, v. 29, n. 8, p. 4, doi. 10.1002/pu.30345
- Publication type:
- Article
Works matching IS 10685308 AND DT 2018 AND VI 29 AND IP 8
Results: 8
1
2
Your Medication Information.
- Published in:
- Brown University Psychopharmacology Update, 2018, v. 29, n. 8, p. 1, doi. 10.1002/pu.30348
- Publication type:
- Article
3
Enforcement.
- Published in:
- Brown University Psychopharmacology Update, 2018, v. 29, n. 8, p. 8, doi. 10.1002/pu.30347
- Publication type:
- Article
4
Research Roundup.
- Published in:
- Brown University Psychopharmacology Update, 2018, v. 29, n. 8, p. 7, doi. 10.1002/pu.30346
- Publication type:
- Article
5
Study supports continuous antipsychotic treatment for first‐episode schizophrenia.
- Published in:
- Brown University Psychopharmacology Update, 2018, v. 29, n. 8, p. 3, doi. 10.1002/pu.30344
- Publication type:
- Article
6
Escitalopram‐associated hyponatremia.
- Published in:
- Brown University Psychopharmacology Update, 2018, v. 29, n. 8, p. 2, doi. 10.1002/pu.30343
- By:
- Publication type:
- Article
7
Preliminary study finds intranasal esketamine benefits patients at risk of suicide.
- Published in:
- Brown University Psychopharmacology Update, 2018, v. 29, n. 8, p. 1, doi. 10.1002/pu.30342
- Publication type:
- Article
8
Lamotrigine fails to show effectiveness in borderline personality disorder trial.
- Published in:
- Brown University Psychopharmacology Update, 2018, v. 29, n. 8, p. 1, doi. 10.1002/pu.30341
- Publication type:
- Article